Allakos, Inc. is a company in the U.S. stock market and it is a holding in 35 U.S.-traded ETFs. ALLK has around 1.9M shares in the U.S. ETF market. The largest ETF holder of ALLK is the iShares NASDAQ Biotechnology ETF (IBB), with approximately 457.58K shares. Investors may also find of interest that the ETF with the largest allocation to ALLK stock is ALPS Medical Breakthroughs ETF (SBIO), with a portfolio weight of 3.14%. On average, U.S. ETFs allocate 0.24% of ALLK to their portfolios.
Additionally, ALLK is a favorite stock for Vanilla and Equal ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ALLK as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 27.53%.